25 LLC’s Sensus Healthcare SRTS Stock Holding History

25 LLC’s Portfolio SRTS Stock Details SRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-187	Closed	-$659	–	490
2023 Q2	$659	Buy	+187	New	+$676	﹤0.01%	347

Other funds holding SRTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

25 LLC's SRTS Position: Q3 2023 in Review

25 LLC sold out of Sensus Healthcare (SRTS) in Q3 2023, closing a stake of 187 shares — an estimated $659 sold.

25 LLC first reported a position in SRTS in Q2 2023 and held it in 1 quarter. The position peaked at $659 in Q2 2023. 40 funds tracked by Wall St. Rank hold SRTS as of Q3 2023.

25 LLC reported no remaining Sensus Healthcare position as of Q3 2023 after selling out during the quarter.
25 LLC sold 187 Sensus Healthcare shares in Q3 2023, an estimated $659.
25 LLC first reported a position in Sensus Healthcare in Q2 2023 and held it in 1 quarter.
25 LLC's Sensus Healthcare position peaked at $659 in Q2 2023.
40 funds tracked by Wall St. Rank held Sensus Healthcare as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.